InvestorsHub Logo
Followers 253
Posts 17921
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Sunday, 10/04/2015 4:29:44 PM

Sunday, October 04, 2015 4:29:44 PM

Post# of 345786
Valeant has not seen the last of this, and I have thought twice about any advantage of PPHM being subject of a TO from VRX:

http://www.nytimes.com/2015/10/05/business/valeants-drug-price-strategy-enriches-it-but-infuriates-patients-and-lawmakers.html

Greed yet prevails, so far...

Roll-up acquisition history:

https://en.wikipedia.org/wiki/Valeant_Pharmaceuticals
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News